Espirito Santo has downgraded Bangalore-based Biocon to "sell" from "neutral" and sharply revised its target price to Rs 186 a share from Rs 350, flagging off several issues, which it says raise accounting and corporate governance questions over at the biotech firm. The investment bank points out to two issues in particular. The latest being Pfizer scrapping a deal to sell insulin products made by Biocon. Changed priorities at Pfizer...
12:10 PM, May 22, 2012
New Delhi: Biocon and US drug major Pfizer on Tuesday called off $350 million global alliance to commercialise the Bangalore-based firm's biosimilar versions of insulin and insulin analog products. "The companies have agreed that due to the individual priorities for their respective biosimilars businesses, it is in their best interest to move forward independently," the two said in a joint statement. In October 2010, they entered into a strategic global...
12:08 PM, Mar 13, 2012
Boston: Regeneron Pharmaceuticals Inc said on Monday that US regulators placed the company's experimental pain drug for osteoarthritis on clinical hold after a patient in another company's trial developed a serious bone disorder. Regeneron said it and its partner, Sanofi-Aventis SA, were informed late last week by the US Food and Drug Administration that the drug, REGN475/SAR164877, was being placed on clinical hold after a patient in another company's trial...
09:53 AM, Dec 28, 2010
London: Britain's state-run health service will get a partial rebate from GlaxoSmithKline if the company's new kidney cancer drug Votrient does not match up to a rival medicine in a head-to-head clinical trial. The unusual deal, the first of its kind, hints at the type of complex arrangements that could become commonplace as Britain moves to a system of value-based drug pricing from the end of 2013. Draft guidance from...
10:25 AM, Dec 24, 2010
India topped the list with people saying they were satisfied with their sex lives. ...
07:58 PM, Feb 25, 2009
The move will give Ranbaxy access to over $1 billion in sales revenue. ...
02:06 AM, Jun 19, 2008
Foreign drugs used for treating erectile dysfunction may soon be passe in India. ...
09:19 PM, Jun 05, 2008
Kris Srikkanth hailed brilliant knock by Virender Sehwag and feels it's a right time to get back to form. ...
08:04 AM, Mar 28, 2008
Chittagong: Having already bagged the one-day international (ODI) series against Bangladesh, Pakistan will be looking to go a step further and register a series whitewash, when the two teams go head to head in the third and final match at Chittagong on Tuesday. Earlier on Saturday, Umar Gul took four wickets as Pakistan beat Bangladesh by 76 runs in the second ODI in Dhaka. Gul finished with 4 for 36...
08:39 AM, Mar 27, 2008
Durban: Former West Indies captain Chris Gayle has signed to play for South African franchise the Dolphins in the South African domestic Twenty20 (T20) competition, the Durban-based team announced on Thursday. Gayle, 31, has been involved in a protracted dispute with the West Indies Cricket Board and has not turned out for the team since he played in a World Cup quarter-final against Pakistan in Dhaka on March 23. The...
05:42 PM, Feb 27, 2008
displayed with permission. Use of the CNN name and/or logo on or as part of CNN-IBN does not derogate from the intellectual property rights of Cable News Network in respect of them.
Disclaimer: Network18 Media & Investments Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
Disclaimer: TV18 Broadcast Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
